Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;22(1):670.
doi: 10.3892/etm.2021.10102. Epub 2021 Apr 23.

NAD+ metabolism and retinal degeneration (Review)

Affiliations
Review

NAD+ metabolism and retinal degeneration (Review)

Andreea Silvia Pîrvu et al. Exp Ther Med. 2021 Jul.

Abstract

The recent years has revealed an intense interest in the study of nicotinamide adenine dinucleotide (NAD+), particularly in regards to its intermediates, such as nicotinamide and nicotinic acid known as niacin, and also nicotinamide riboside. Besides its participation as a coenzyme in the redox transformations of nutrients during catabolism, NAD+ is also involved in DNA repair and epigenetic modification of gene expression and also plays an essential role in calcium homeostasis. Clinical and experimental data emphasize the age-dependent decline in NAD+ levels and its relation with the onset and progression of various age-related diseases. Maintaining optimal levels of NAD+ has aroused a therapeutic interest in such pathological conditions; NAD+ being currently regarded as an important target to extend health and lifespan. Based on a systematic exploration of the experimental data and literature surrounding the topic, this paper reviews some of the recent research studies related to the roles of the pyridine nucleotide family focusing on biosynthesis, NAD+ deficiency-associated diseases, pathobiochemistry related to retinal degeneration and potential therapeutic effects on human vision as well.

Keywords: NAD+; NAD+ therapeutic target; niacin; nicotinamide riboside; pyridine nucleotide family; retinal degeneration.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Reactions involved in NAD+ synthesis through the salvage pathway. NAD+, nicotinamide adenine dinucleotide; NMN, nicotinamide mononucleotide; PPi, inorganic pyrophosphate; PRPP, phosphoribosyl pyrophosphate; Nampt, nicotinamide phosphoribosyltransferase; Nmnat, nicotinamide mononucleotide adenylyltransferase; ATP, Adenosine triphosphate.

References

    1. Clement J, Wong M, Poljak A, Sachdev P, Braidy N. The plasma NAD+ metabolome is dysregulated in ‘normal’ aging. Rejuvenation Res. 2019;22:121–130. doi: 10.1089/rej.2018.2077. - DOI - PMC - PubMed
    1. Surjana D, Halliday GM, Damian DL. Role of nicotinamide in DNA damage, mutagenesis, and DNA repair. J Nucleic Acids. 2010;2010(157591) doi: 10.4061/2010/157591. - DOI - PMC - PubMed
    1. Braidy N, Beg J, Clement J, Khorshidi F, Poljak A, Jayasena T, Grant R, Sachdev P. Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets for age-related degenerative diseases: Rationale, biochemistry, pharmacokinetics, and outcomes. Antioxid Redox Signal. 2019;30:251–294. doi: 10.1089/ars.2017.7269. - DOI - PMC - PubMed
    1. Horenstein AL, Sizzano F, Lusso R, Besso FG, Ferrero E, Deaglio S, Corno F, Malavasi F. CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus. Mol Med. 2009;15:76–84. doi: 10.2119/molmed.2008.00108. - DOI - PMC - PubMed
    1. Croft T, Venkatakrishnan P, Lin SJ. NAD+ metabolism and regulation: Lessons from yeast. Biomolecules. 2020;10(330) doi: 10.3390/biom10020330. - DOI - PMC - PubMed